Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-11

FDA Approved: EVKEEZA — Original Application (Regeneron Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original Biologics License Application for EVKEEZA (evinacumab) from Regeneron Pharmaceuticals for the treatment of homozygous familial hyperch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evkeeza (evinacumab)

Snippet

ORIG AP for EVKEEZA (EVINACUMAB)